Arcutis Biotherapeutics, Inc. (ARQT) Stock

Arcutis Biotherapeutics, Inc. (ARQT) is a Healthcare stock trading at $26.19 (as of 2026-06-18), with a market capitalization of $2.67B and a trailing P/E of -1219.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing dermatology treatments. It is advancing topical candidates including ARQ-151 for plaque psoriasis and atopic dermatitis (Phase III completed), along with ARQ-154, ARQ-252, and ARQ-255 for other skin conditions.

Valuation — source: SEC EDGAR (first-party)
Price$26.19
Market Cap$2.67B
P/E Ratio-1219.0
EV / EBITDA798.3
Price / Book16.08
Price / Sales7.34
DCF Value (model)$-1.40
DCF Upside vs Price-105.3%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$376.07M
Net Margin-4.3%
Return on Equity-1.3%
Debt / Equity0.58
Current Ratio2.68
Revenue Growth (YoY)91.3%
EPS Growth (YoY)-88.8%
FCF Growth (YoY)-94.4%
Financial Health — source: SEC EDGAR
Altman Z-Score5.88 (safe)
Piotroski F-Score4/9 (moderate)
Valuation vs Sector & Industry
Stock P/E-1219.0
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-5916.0%
vs Industry-7162.1%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Insider Sells (12mo)53
Top Institutional HolderSUVRETTA CAPITAL MANAGEMENT, LLC ($290.42M)
Institutional Holders Tracked10
Congressional Trades (recent)6
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOTodd Franklin Watanabe
Employees342
CountryUS
IPO Date2020-01-31

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Mirum Pharmaceuticals, Inc. (MIRM)
  • Amneal Pharmaceuticals, Inc. (AMRX)
  • NewAmsterdam Pharma Company N.V. (NAMS)
  • Ligand Pharmaceuticals Incorporated (LGND)
  • Corcept Therapeutics Incorporated (CORT)
  • CG Oncology, Inc. Common stock (CGON)
  • Kiniksa Pharmaceuticals, Ltd. (KNSA)
  • Dyne Therapeutics, Inc. (DYN)
ARQT earnings history · ARQT institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.